Overweight modulates APOE and APOA5 alleles on the risk of severe hypertriglyceridemia

Clinica Chimica Acta

Volumn 416, Issue , 2013, Pages 31-35

  Lee, Ming Jen ^a   Chien, Kuo Liong ^a,b   Chen, Ming Fong ^a   Stephenson, Dennis A ^c   Su, Ta Chen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c MCLAUGHLIN RESEARCH INSTITUTE   (United States)

Author keywords

APOA5 'T'; APOE4; Genetic polymorphism; Hypertriglyceridemia; Overweight

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; APOA5 GENE; APOE GENE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; GENE IDENTIFICATION; GENE INTERACTION; GENE SEQUENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

ADULT; ALLELES; APOLIPOPROTEINS A; APOLIPOPROTEINS E; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVERWEIGHT; POLYMORPHISM, GENETIC;

EID: 84871008094     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.054     Document Type: Article

References (33)

1. Brunzell J.D., Albers J.J., Chait A., Grundy S.M., Groszek E., McDonald G.B. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 1983, 24(2):147-155.
2. Neil H.A., Cooper J., Betteridge D.J., et al. All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: a long-term prospective registry study. Atherosclerosis 2010, 211(2):618-623.
3. Eichner J.E., Dunn S.T., Perveen G., Thompson D.M., Stewart K.E., Stroehla B.C. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002, 155(6):487-495.
4. Heller D.A., de F.U., Pedersen N.L., Dahlen G., McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 1993, 328(16):1150-1156.
5. McCarron M.O., Delong D., Alberts M.J. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999, 53(6):1308-1311.
6. Orth M., Wahl S., Hanisch M., Friedrich I., Wieland H., Luley C. Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype. Biochim Biophys Acta 1996, 1303(1):22-30.
7. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 1992, 33(4):447-454.
8. Katsuya T., Baba S., Ishikawa K., et al. Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study. J Hypertens 2002, 20(10):2017-2021.
9. Eto M., Watanabe K., Ishii K. Apolipoprotein E polymorphism and hyperlipoproteinemia in obesity. Int J Obes 1989, 13(4):433-440.
10. Fumeron F., Rigaud D., Bertiere M.C., Bardon S., Dely C., Apfelbaum M. Association of apolipoprotein epsilon 4 allele with hypertriglyceridemia in obesity. Clin Genet 1988, 34(4):258-264.
11. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294(5540):169-173.
12. Hsu L.A., Ko Y.L., Chang C.J., et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 2006, 185(1):143-149.
13. Kao J.T., Wen H.C., Chien K.L., Hsu H.C., Lin S.W. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 2003, 12(19):2533-2539.
14. Matsunaga A., Arishima H., Niimura H., et al. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Circ J 2007, 71(5):746-752.
15. Merkel M., Loeffler B., Kluger M., et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 2005, 280(22):21553-21560.
16. Koike T., Liang J., Wang X., et al. Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. J Biol Chem 2004, 279(9):7521-7529.
17. Wang J., Ban M.R., Zou G.Y., et al. Polygenic determinants of severe hypertriglyceridemia. Hum Mol Genet 2008, 17(18):2894-2899.
18. Elosua R., Demissie S., Cupples L.A., et al. Obesity modulates the association among APOE genotype, insulin, and glucose in men. Obes Res 2003, 11(12):1502-1508.
19. Marques-Vidal P., Bongard V., Ruidavets J.B., et al. Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin. Obes Res 2003, 11(10):1200-1206.
20. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143-3421.
21. Pantelidis P., Lambert-Hammill M., Wierzbicki A.S. Simple sequence-specific-primer-PCR method to identify the three main apolipoprotein E haplotypes. Clin Chem 2003, 49(11):1945-1948.
22. Ceppellini R., Siniscalco M., Smith C.A. The estimation of gene frequencies in a random-mating population. Ann Hum Genet 1955, 20(2):97-115.
23. Jemaa R., Elasmi M., Naouali C., et al. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters. Clin Biochem 2006, 39(8):816-820.
24. Yuan G., Al-Shali K.Z., Hegele R.A. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007, 176(8):1113-1120.
25. Sousa M.O., Alia P., Pinto X., Corbella E., Navarro M.A. Interaction between APOA5-1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia. Clin Chim Acta 2008, 395(1-2):68-71.
26. Chien K.L., Fang W.H., Wen H.C., et al. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta 2008, 390(1-2):56-62.
27. Evans A.E., Zhang W., Moreel J.F., et al. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men. Hum Genet 1993, 92(2):191-197.
28. Kao J.T., Tsai K.S., Chang C.J., Huang P.C. The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 1995, 114(1):55-59.
29. Shen X., Xia Y., Sass C., Visvikis S., Siest G. Association of apolipoprotein E polymorphism and concentration with serum lipids and apolipoprotein level in the Chinese from Shanghai. Clin Chem Lab Med 1998, 36(8):615-619.
30. Chien K.L., Chen M.F., Hsu H.C., et al. Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population. Clin Chim Acta 2008, 388(1-2):78-83.
31. Aberle J., Evans D., Beil F.U., Seedorf U. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet 2005, 68(2):152-154.
32. Corella D., Lai C.Q., Demissie S., et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med 2007, 85(2):119-128.
33. Valdivielso P., Sanchez-Chaparro M.A., Calvo-Bonacho E., et al. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study. Atherosclerosis 2009, 207(2):573-578.